Wai Yuen Tong Medicine Holdings Limited (0897.HK)
HKD 0.34
(1.49%)
HKD 0.34
(1.49%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 394.81 Million HKD | -35.23% |
| 2022 | 609.54 Million HKD | 6.16% |
| 2021 | 574.15 Million HKD | 28.09% |
| 2020 | 448.25 Million HKD | 58.82% |
| 2019 | 282.23 Million HKD | -6.4% |
| 2018 | 301.52 Million HKD | -12.29% |
| 2017 | 343.79 Million HKD | 10.63% |
| 2016 | 310.76 Million HKD | -16.06% |
| 2015 | 370.21 Million HKD | 5.47% |
| 2014 | 351.02 Million HKD | -9.88% |
| 2013 | 389.49 Million HKD | 6.62% |
| 2012 | 365.31 Million HKD | 3.09% |
| 2011 | 354.37 Million HKD | 17.49% |
| 2010 | 301.61 Million HKD | 19.51% |
| 2009 | 252.37 Million HKD | 10.36% |
| 2008 | 228.67 Million HKD | 3.28% |
| 2007 | 221.4 Million HKD | 26.29% |
| 2006 | 175.31 Million HKD | 30.98% |
| 2005 | 133.85 Million HKD | -18.77% |
| 2004 | 164.77 Million HKD | 6.23% |
| 2003 | 155.11 Million HKD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q2 | 325.23 Million HKD | 0.0% |
| 2023 FY | 394.81 Million HKD | -35.23% |
| 2023 Q4 | 53.49 Million HKD | 0.0% |
| 2022 Q2 | 272.46 Million HKD | 0.0% |
| 2022 FY | 609.54 Million HKD | 6.16% |
| 2022 Q4 | 337.07 Million HKD | 0.0% |
| 2021 Q4 | 297.61 Million HKD | 0.0% |
| 2021 FY | 574.15 Million HKD | 28.09% |
| 2021 Q2 | 276.53 Million HKD | 0.0% |
| 2020 Q4 | 273.57 Million HKD | 0.0% |
| 2020 Q2 | 174.68 Million HKD | 0.0% |
| 2020 FY | 448.25 Million HKD | 58.82% |
| 2019 FY | 282.23 Million HKD | -6.4% |
| 2019 Q4 | 169.69 Million HKD | 0.0% |
| 2019 Q2 | 112.54 Million HKD | 0.0% |
| 2018 FY | 301.52 Million HKD | -12.29% |
| 2018 Q4 | 165.02 Million HKD | 0.0% |
| 2018 Q2 | 136.5 Million HKD | 0.0% |
| 2017 Q2 | 150.52 Million HKD | 0.0% |
| 2017 Q4 | 193.26 Million HKD | 0.0% |
| 2017 FY | 343.79 Million HKD | 10.63% |
| 2016 Q4 | 154.44 Million HKD | 0.0% |
| 2016 Q2 | 156.31 Million HKD | 0.0% |
| 2016 FY | 310.76 Million HKD | -16.06% |
| 2015 Q2 | 163.01 Million HKD | 0.0% |
| 2015 Q4 | 207.2 Million HKD | 0.0% |
| 2015 FY | 370.21 Million HKD | 5.47% |
| 2014 Q2 | 160.65 Million HKD | 64.99% |
| 2014 FY | 351.02 Million HKD | -9.88% |
| 2014 Q3 | 87.75 Million HKD | -45.37% |
| 2014 Q4 | 87.75 Million HKD | 0.0% |
| 2014 Q1 | 97.37 Million HKD | 0.0% |
| 2013 FY | 389.49 Million HKD | 6.62% |
| 2013 Q4 | 97.37 Million HKD | 0.0% |
| 2013 Q3 | 97.37 Million HKD | -48.79% |
| 2013 Q2 | 190.14 Million HKD | 108.2% |
| 2013 Q1 | 91.32 Million HKD | 0.0% |
| 2012 Q1 | 88.59 Million HKD | 0.0% |
| 2012 Q2 | 88.59 Million HKD | 0.0% |
| 2012 Q3 | 91.32 Million HKD | 3.09% |
| 2012 Q4 | 91.32 Million HKD | 0.0% |
| 2012 FY | 365.31 Million HKD | 3.09% |
| 2011 Q1 | 75.4 Million HKD | 0.0% |
| 2011 FY | 354.37 Million HKD | 17.49% |
| 2011 Q4 | 88.59 Million HKD | 0.0% |
| 2011 Q3 | 88.59 Million HKD | 17.49% |
| 2011 Q2 | 75.4 Million HKD | 0.0% |
| 2010 Q4 | 75.4 Million HKD | 0.0% |
| 2010 FY | 301.61 Million HKD | 19.51% |
| 2010 Q1 | 63.09 Million HKD | 0.0% |
| 2010 Q2 | 63.09 Million HKD | 0.0% |
| 2010 Q3 | 75.4 Million HKD | 19.51% |
| 2009 Q1 | 57.16 Million HKD | 0.0% |
| 2009 Q2 | 57.16 Million HKD | 0.0% |
| 2009 Q3 | 63.09 Million HKD | 10.36% |
| 2009 FY | 252.37 Million HKD | 10.36% |
| 2009 Q4 | 63.09 Million HKD | 0.0% |
| 2008 Q2 | 55.35 Million HKD | 0.0% |
| 2008 Q4 | 57.16 Million HKD | 0.0% |
| 2008 Q3 | 57.16 Million HKD | 3.28% |
| 2008 Q1 | 55.35 Million HKD | 0.0% |
| 2008 FY | 228.67 Million HKD | 3.28% |
| 2007 Q2 | 43.82 Million HKD | 0.0% |
| 2007 Q1 | 43.82 Million HKD | 0.0% |
| 2007 FY | 221.4 Million HKD | 26.29% |
| 2007 Q4 | 55.35 Million HKD | 0.0% |
| 2007 Q3 | 55.35 Million HKD | 26.29% |
| 2006 Q3 | 43.82 Million HKD | 30.98% |
| 2006 Q2 | 33.46 Million HKD | 0.0% |
| 2006 Q1 | 33.46 Million HKD | 0.0% |
| 2006 FY | 175.31 Million HKD | 30.98% |
| 2006 Q4 | 43.82 Million HKD | 0.0% |
| 2005 Q3 | 33.46 Million HKD | -18.77% |
| 2005 FY | 133.85 Million HKD | -18.77% |
| 2005 Q1 | 41.19 Million HKD | 0.0% |
| 2005 Q2 | 41.19 Million HKD | 0.0% |
| 2005 Q4 | 33.46 Million HKD | 0.0% |
| 2004 Q4 | 41.19 Million HKD | 0.0% |
| 2004 Q1 | 38.77 Million HKD | 0.0% |
| 2004 FY | 164.77 Million HKD | 6.23% |
| 2004 Q3 | 41.19 Million HKD | 6.23% |
| 2004 Q2 | 38.77 Million HKD | 0.0% |
| 2003 Q3 | 38.77 Million HKD | 0.0% |
| 2003 FY | 155.11 Million HKD | 0.0% |
| 2003 Q4 | 38.77 Million HKD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 167.43 Million HKD | -135.799% |
| Grand Pharmaceutical Group Limited | 6.52 Billion HKD | 93.948% |
| Extrawell Pharmaceutical Holdings Limited | 28.77 Million HKD | -1271.879% |
| Qianhai Health Holdings Limited | -35.6 Million HKD | 1208.932% |
| Lee's Pharmaceutical Holdings Limited | 551.31 Million HKD | 28.387% |
| Essex Bio-Technology Limited | 1.53 Billion HKD | 74.351% |
| Tongfang Kontafarma Holdings Limited | 471.29 Million HKD | 16.228% |
| PuraPharm Corporation Limited | 216.62 Million HKD | -82.253% |
| SSY Group Limited | 3.48 Billion HKD | 88.685% |
| JBM (Healthcare) Limited | 319.41 Million HKD | -23.605% |
| Jacobson Pharma Corporation Limited | 620.47 Million HKD | 36.369% |
| China Resources Pharmaceutical Group Limited | 43.36 Billion HKD | 99.09% |